Publications

Correlation Between Soluble Suppression of Tumorigenicity 2 (Sst2) and Endoscopic Activity in Patients with Moderate to Severe Ulcerative Colitis Under Golimumab Treatment: Results of the Evolution Study

AuthID
P-00Q-AJS

Author(s)

Magro, F

Lopes, S

Silva, M

Coelho, R

Portela, F

Branquinho, D

Correia, L

Fernandes, S

Cravo, M

Caldeira, P

Sousa, H

Patita, M

Lago, P

Ramos, J

Afonso, J

Redondo, I

Machado, P

Philip, G

Lopes, J

Carneiro, F

Document Type

Abstract

Year published

2019

Published

in JOURNAL OF CROHNS & COLITIS, ISSN: 1873-9946

Volume: 13, Pages: S363-S363 (1)

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1093/ecco-jcc/jjy222.626

Wos: WOS:000460544502059

Source Identifiers

ISSN: 1873-9946

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Correlation Between Soluble Suppression of Tumorigenicity 2 (Sst2) and Endoscopic Activity in Patients with Moderate to Severe Ulcerative Colitis Under Golimumab Treatment: Results of the Evolution Study

Useful Links

Get Help

Federated Authentication (Click on the image)

Correlation Between Soluble Suppression of Tumorigenicity 2 (Sst2) and Endoscopic Activity in Patients with Moderate to Severe Ulcerative Colitis Under Golimumab Treatment: Results of the Evolution Study

Useful Links

Get Help